search
Back to results

Effectiveness of Hysteroscopy in the Treatment of Intrauterine Trophoblastic Retentions (HY-PER)

Primary Purpose

Incomplete Miscarriage

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Hysteroscopy
Curettage
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Incomplete Miscarriage focused on measuring Incomplete miscarriage, Hysteroscopy, curettage, pregnancy, RCT

Eligibility Criteria

18 Years - 44 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Major, under 45 years with intrauterine trophoblastic retention after incomplete miscarriage in the first quarter (termination of pregnancy < 14 WA),
  • With desire of pregnancy ;
  • Intrauterine trophoblastic retention diagnosed by transvaginal pelvic ultrasound finding a intrauterine heterogeneous image or intrauterine gestational sac more than 15 mm in thickness, complicated or not of endometritis ;
  • Decision to surgical management of incomplete miscarriage by the health care team ;
  • Patient beneficiary or affiliated to a health insurance
  • Informed and signed consent

Exclusion Criteria:

Will not be included in the protocol patients :

  • having a uterine malformation known ;
  • having received surgical treatment for the current intrauterine retention ;
  • with intrauterine retention diagnosed by transvaginal pelvic ultrasound of more than 50 mm in thickness ;
  • requiring a haemostatic act in urgency for heavy vaginal bleeding (miscarriage haemorrhage) ;
  • bearer of intrauterine device ;
  • having an evolutive pregnancy;
  • having an ectopic pregnancy;
  • having a trophoblastic retention following a voluntary abortion ;
  • having a pregnancy achieved by medically assisted procreation

Sites / Locations

  • Centre hospitalier intercommunal de poissy-saint germain en Laye

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Arm A : Operative hysteroscopy

Arm B : Aspirative curettage

Arm Description

operative hysteroscopy with direct visualization

curettage is the standard surgical treatment in most centers

Outcomes

Primary Outcome Measures

Progressive intrauterine pregnancy > 22 WA
Questionnaire

Secondary Outcome Measures

Next pregnancy
Surgical complications' rate
Clavien-Dindo classification
Surgical reinterventions

Full Information

First Posted
July 17, 2014
Last Updated
July 17, 2020
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT02201732
Brief Title
Effectiveness of Hysteroscopy in the Treatment of Intrauterine Trophoblastic Retentions
Acronym
HY-PER
Official Title
Assessment of the Effectiveness of Hysteroscopy in the Treatment of Intrauterine Trophoblastic Retentions
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
November 5, 2014 (Actual)
Primary Completion Date
November 15, 2019 (Actual)
Study Completion Date
July 3, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study of is to compare subsequent fertility rates between hysteroscopy and aspirative curettage in the surgical treatment of incomplete spontaneous abortion
Detailed Description
Incomplete spontaneous abortion (ISA) is defined by the intrauterine retention of conceptual product after incomplete or partial expulsion of the conceptual product. Treatment such retention may be expectant care, medical treatment or surgery. Currently, curettage is the standard surgical treatment in most centers. However, operative hysteroscopy, in addition to the direct visualization of the retained conceptual product, in contrast to the curettage, would allow elective evacuation of retention while reducing surgical complications. Studies of low effective, retrospective, have found an fertility's increase in patients treated by operative hysteroscopy. These data need to be confirmed by a randomized controlled trial in order to change the standard surgical treatment of this disease if hysteroscopy procedure would found to be superior. We propose a multicenter - single blind - randomized - therapeutic study. Randomization will concern the surgical procedure in patients treated surgically for intrauterine retention after spontaneous miscarriage. Randomization will be performed at the admission to the patient in the operating room by electronic means using a secure internet platform, single-blind for the patient with unblinding at the end of the trial or in case of complication. The patient will be randomly assigned to one of two treatment arms following: Arm A : Operative hysteroscopy Arm B : Aspirative curettage The inclusion will be performed at time of diagnosis (incomplete miscarriage) with an ultrasound of intrauterine retention for which surgical treatment has been decided. The initial medical examination (inclusion visit) will include a complete gynecological examination. The diagnosis of incomplete miscarriage will be performed using a transvaginal pelvic ultrasound. Transvaginal ultrasound will be performed according to a technique of standardized pelvic ultrasound ; the retention will be diagnosed in the presence of a heterogeneous image or intrauterine gestational sac more than 15 mm in thickness. On this visit, the patient will complete a questionnaire concerning her medical histories and the aborted pregnancy. Patients will have a care in accordance with center practices for the hospital stay. Surgical treatment will be performed within the time depending on the availability of the operating room of participating center. A hospitalization report indicating the participation to the study, but not mentioning the treatment group, will be sent to the attending physician and the patient. An information form with postoperative instructions will be given to patients included in this protocol without mentioning the surgical arm. The operative report will be given to the patient at the end of her participation in the trial. A total of five visits (including final visit) are scheduled for this trial. The patient will be monitored in the form of telephone conversation or questionnaire sent by email or post. Monitoring will be done by the investigator that enrolled the patient with the help of the URC in charge of the project. In case of complications, failure of the intervention or diagnosis of a uterine cavity pathology, the care will be left to the discretion of the medical center team.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Incomplete Miscarriage
Keywords
Incomplete miscarriage, Hysteroscopy, curettage, pregnancy, RCT

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
577 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Arm A : Operative hysteroscopy
Arm Type
Experimental
Arm Description
operative hysteroscopy with direct visualization
Arm Title
Arm B : Aspirative curettage
Arm Type
Active Comparator
Arm Description
curettage is the standard surgical treatment in most centers
Intervention Type
Procedure
Intervention Name(s)
Hysteroscopy
Intervention Description
Performed under general or local anesthesia, antibioprophylaxis in accordance to center practices may be administered. Cervical dilatation, will be made in order to introduce the hysteroscope. Operative hysteroscope used will include a handle. The distension of the uterine cavity will be performed with physiological saline or glycocoll, depending on the polarity of the high frequency generator necessary for resection system (monopolar or bipolar), with a pressure of maximum irrigation of 110 mm Hg.
Intervention Type
Procedure
Intervention Name(s)
Curettage
Intervention Description
Performed under general or local anesthesia, the used material may be rigid or flexible vacurette. In the same way, the prophylactic antibiotic, the diameter of the used vacurette, the importance of cervical dilation necessary and a possible peroperative ultrasound guidance will be left at the discretion of the operator and habits of the center. A check of the uterine vacuity by foam curette will be conducted at the end of curettage.
Primary Outcome Measure Information:
Title
Progressive intrauterine pregnancy > 22 WA
Description
Questionnaire
Time Frame
Until 2 years post surgery
Secondary Outcome Measure Information:
Title
Next pregnancy
Time Frame
Until 2 years post surgery
Title
Surgical complications' rate
Description
Clavien-Dindo classification
Time Frame
until 2 years post surgery
Title
Surgical reinterventions
Time Frame
until 2 years post surgery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
44 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Major, under 45 years with intrauterine trophoblastic retention after incomplete miscarriage in the first quarter (termination of pregnancy < 14 WA), With desire of pregnancy ; Intrauterine trophoblastic retention diagnosed by transvaginal pelvic ultrasound finding a intrauterine heterogeneous image or intrauterine gestational sac more than 15 mm in thickness, complicated or not of endometritis ; Decision to surgical management of incomplete miscarriage by the health care team ; Patient beneficiary or affiliated to a health insurance Informed and signed consent Exclusion Criteria: Will not be included in the protocol patients : having a uterine malformation known ; having received surgical treatment for the current intrauterine retention ; with intrauterine retention diagnosed by transvaginal pelvic ultrasound of more than 50 mm in thickness ; requiring a haemostatic act in urgency for heavy vaginal bleeding (miscarriage haemorrhage) ; bearer of intrauterine device ; having an evolutive pregnancy; having an ectopic pregnancy; having a trophoblastic retention following a voluntary abortion ; having a pregnancy achieved by medically assisted procreation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Arnaud FAUCONNIER, MD, PhD
Organizational Affiliation
Centre Hospitalier Intercommunal de Poissy / Saint-Germain
Official's Role
Study Director
Facility Information:
Facility Name
Centre hospitalier intercommunal de poissy-saint germain en Laye
City
Poissy
ZIP/Postal Code
78300
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
34061352
Citation
Ghosh J, Papadopoulou A, Devall AJ, Jeffery HC, Beeson LE, Do V, Price MJ, Tobias A, Tuncalp O, Lavelanet A, Gulmezoglu AM, Coomarasamy A, Gallos ID. Methods for managing miscarriage: a network meta-analysis. Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602. doi: 10.1002/14651858.CD012602.pub2.
Results Reference
derived
PubMed Identifier
26282937
Citation
Huchon C, Koskas M, Agostini A, Akladios C, Alouini S, Bauville E, Bourdel N, Fernandez H, Fritel X, Graesslin O, Legendre G, Lucot JP, Matheron I, Panel P, Raiffort C, Fauconnier A. Operative hysteroscopy versus vacuum aspiration for incomplete spontaneous abortion (HY-PER): study protocol for a randomized controlled trial. Trials. 2015 Aug 19;16:363. doi: 10.1186/s13063-015-0900-1.
Results Reference
derived

Learn more about this trial

Effectiveness of Hysteroscopy in the Treatment of Intrauterine Trophoblastic Retentions

We'll reach out to this number within 24 hrs